Taisho Pharmaceutical Co., Ltd.

News Releases News Releases HOME HOME



September 11, 2003

Announcing the Launch of Hemorrhoidal Preparations "Preser S Hi Ointment" and "Preser S Hi" Packaged to be More Accessible to Women

 



Taisho Pharmaceutical Co., Ltd. (President: Akira Uehara) will launch the hemorrhoidal preparations "Preser S Hi Ointment" and "Preser S Hi" which are packaged to be more accessible to women on September 16 to broaden the "Preser" series of hemorrhoidal preparations.

Research conducted by the Ministry of Health, Labour and Welfare in 1999 indicated that women account for 44% of all hemorrhoid patients. Many women experience hemorrhoids during pregnancy and delivery. Additionally, the constipation commonly experienced by women is considered to be one of the causes of this phenomenon.

A case of hemorrhoids isn’t something most people want others to know about. When women buy a hemorrhoidal drug over the counter, they may prefer to select a product, for example, that is discreetly packaged so as not to identify it as a hemorrhoidal drug. The "Preser S Hi" series is packaged in this way.

The "Preser S Hi" series of products is available in two forms: ointment and suppository. The ointment-type products are effective against swelling of blind piles outside the anus and bleeding associated with anal fissures, and are used at the start of treatment in more than 60% of women with hemorrhoids. 
With suppository-type products, a Preser-exclusive pharmaceutical technique (W-DDS*) is used. This type of product is particularly effective against swelling and bleeding associated with blind piles inside the anus, as its base material allows the suppository to remain at the affected area, while its vasoconstrictor activity allows the active ingredients to remain at the affected area for an extended period.
* DDS:  Drug Delivery System (a technique for efficiently delivering the drug to the affected area)


Product specification for "Preser S Hi Ointment"

Suggested retail price 12g  ¥1,200
Ingredients (per 100g)
Hydrocortisone acetate 0.5 g
Tetrahydrozoline hydrochloride 0.05 g
Tocopherol acetate 3 g
Lidocaine 3 g
Chlorpheniramine maleate 0.2 g
l-menthol 0.2 g
Allantoin 1 g
Chlorhexidine hydrochloride 0.25 g
Indications Relief of the aching, bleeding, swelling, and itching 
associated with anal fissures and blind piles.
Dosage Apply an appropriate amount to the affected area
1 to 3 times per day.
Date of sale September 16, 2003
Expected sales ¥300 million (one year from date of sale)



Product specification for "Preser S Hi"

Suggested retail price 8 suppositories  ¥1,200
Ingredients (Per suppository [1.65 g])
Hydrocortisone acetate 5 mg
Tetrahydrozoline hydrochloride 1 mg
Tocopherol acetate 60 mg
Lidocaine 60 mg
Chlorpheniramine maleate 4 mg
l-menthol 10 mg
Allantoin 20 mg
Chlorhexidine hydrochloride 5 mg
Indications Relief of the aching, bleeding, swelling, and itching 
associated with anal fissures and blind piles.
Dosage Insert into the anus at the following doses.
Age Single dose Freqency
15 and over 1 suppository 1 to 3 times per day
less than 15 years Do not administer under age 15.
Date of sale September 16, 2003
Expected sales ¥200 million (one year from date of sale)


BACK

Copyright(C) Taisho Pharmaceutical Co., Ltd. 1997-2006.All Rights Reserved.